Case series: CYP Inhibition and low dose ibrutinib for steroid-refractory chronic graft-versus-host disease

被引:1
|
作者
De la Garza-Salazar, Fernando
Colunga-Pedraza, Perla Rocio
Coronado-Alejandro, Edgar Ulises
Gutierrez-Aguirre, Cesar Homero
Cantu-Rodriguez, Olga Graciela
Gomez-Almaguer, David [1 ,2 ]
机构
[1] Univ Autonoma Nuevo Leon, Fac Med, Monterrey, Mexico
[2] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Hematol Serv, Internal Med Dept, Monterrey, Mexico
关键词
chronic graft versus host disease; CYP; ibrutinib; itraconazole; low dose;
D O I
10.1111/bjh.18712
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:573 / 576
页数:4
相关论文
共 50 条
  • [31] Belumosudil for chronic graft-versus-host disease
    Taylor, Breanna
    Cohen, Jaimie
    Tejeda, Jennifer
    Wang, Trent Peng
    DRUGS OF TODAY, 2022, 58 (05) : 203 - 212
  • [32] Biomarkers in chronic graft-versus-host disease
    Rozmus, Jacob
    Schultz, Kirk R.
    EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (03) : 329 - 342
  • [33] Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease
    L Giaccone
    P Martin
    P Carpenter
    C Moravec
    H Hooper
    V A M Funke
    R Storb
    M E D Flowers
    Bone Marrow Transplantation, 2005, 36 : 337 - 341
  • [34] Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease
    Giaccone, L
    Martin, P
    Carpenter, P
    Moravec, C
    Hooper, H
    Funke, VAM
    Storb, R
    Flowers, MED
    BONE MARROW TRANSPLANTATION, 2005, 36 (04) : 337 - 341
  • [35] Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease
    Chen, George L.
    Carpenter, Paul A.
    Broady, Raewyn
    Gregory, Tara K.
    Johnston, Laura J.
    Storer, Barry E.
    Beumer, Jan H.
    Qiu, Jingxin
    Cerda, Kiara
    Le, Ryan
    Otani, Joanne M.
    Liu, Hong
    Ross, Maureen A.
    Arai, Sally
    Flowers, Mary E. D.
    McCarthy, Philip L.
    Miklos, David B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (02) : 373 - 380
  • [36] Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
    Gomez, Virginia Esamilla
    Garcia-Gutierrez, Valentin
    Corral, Lucia Lopez
    Cadenas, Irene Garcia
    Martinez, Ariadna Perez
    Malaver, Francisco J. Marquez
    Caballero-Velazquez, Teresa
    Sierra, Pedro A. Gonzalez
    Alegria, Maria C. Viguria
    Salinas, Ingrid M. Parra
    Cabrera, Cristina Calderon
    Vicent, Marta Gonzalez
    Torres, Nancy Rodriguez
    Porras, Rocio Parody
    Coll, Christelle Ferra
    Orti, Guillermo
    Ferreiras, David Valcarcel
    Llanza, Rafael De la Camara
    Moles, Paula
    Velazquez-Kennedy, Kyra
    Mende, Maria Joao
    Barrigon, Dolores Caballero
    Perez, Estefania
    Bofarull, Rodrigo Martino
    Gerosa, Silvanna Saavedra
    Sierra, Jorge
    Poch, Marc
    Ripa, Maria T. Zudaire
    Perez, Miguel A. Diaz
    Angulo, Blanca Molina
    Ortega, Isabel Sanchez
    Caballer, Jaime Sanz
    Gomez, Juan Montoro
    Tocino, Ildefonso Espigado
    Perez-Simon, Jose A.
    BONE MARROW TRANSPLANTATION, 2020, 55 (03) : 641 - 648
  • [37] Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
    B Mookerjee
    V Altomonte
    G Vogelsang
    Bone Marrow Transplantation, 1999, 24 : 517 - 520
  • [38] Pseudoautologous blood stem cell transplantation for refractory chronic graft-versus-host disease
    Pusic, I
    Pavletic, SZ
    Kessinger, A
    Tarantolo, SR
    Bishop, MR
    BONE MARROW TRANSPLANTATION, 2002, 29 (08) : 709 - 710
  • [39] Pseudoautologous blood stem cell transplantation for refractory chronic graft-versus-host disease
    I Pusic
    SZ Pavletic
    A Kessinger
    SR Tarantolo
    MR Bishop
    Bone Marrow Transplantation, 2002, 29 : 709 - 710
  • [40] Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
    Mookerjee, B
    Altomonte, V
    Vogelsang, G
    BONE MARROW TRANSPLANTATION, 1999, 24 (05) : 517 - 520